BioRegenx (BioRegenx) Total Stockholders Equity : $17.01 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx Total Stockholders Equity?

BioRegenx's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $17.01 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioRegenx's Book Value per Share for the quarter that ended in Mar. 2024 was $0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioRegenx's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.12.

BioRegenx Total Stockholders Equity Historical Data

The historical data trend for BioRegenx's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Total Stockholders Equity Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

0.08

0.18

-0.08

-0.20

-0.22

BioRegenx Quarterly Data
	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															-0.16	-0.15	-0.21	-0.22	17.01

BioRegenx (OTCPK:BRGX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioRegenx's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(17.011	-	0)	/	956.53
	=	0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioRegenx's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.842	+	0.15)	/	17.011
	=	0.12

BioRegenx Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioRegenx's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx (BioRegenx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092

Website

https://www.findit.com

Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.